CIR Experts Seek Data On Cyclomethicone, Re-Open Five Ingredient Reviews
This article was originally published in The Rose Sheet
Executive Summary
The Cosmetic Ingredient Review Expert Panel determined there is insufficient data to confirm the safe use of cyclomethicone in hair- and skin-care products and is requesting further data on individual chain length polymers in the ingredient
You may also be interested in...
FDA Proposal Classifies Skin Bleaching Products As Drugs
FDA is proposing a rule that classifies all over-the-counter skin bleaching products as drugs requiring an approved new drug application, the agency announced in a notice of proposed rulemaking published in an Aug. 29 Federal Register 1notice
Parabens Tentative Amended Final Report Issued By CIR
The Cosmetic Ingredient Review Expert Panel is initiating a 90-day comment period on a tentative amended final safety assessment for parabens, which the panel issued during its Dec. 12-13 meeting in Washington, D.C
Cosmetics Industry Awaits FDA’s Allergen List While Working To Inform GMP Rulemaking
The Independent Beauty Association does not yet have insight into what ingredients will be listed in the US FDA’s proposed rulemaking for cosmetic allergen labeling – due by 29 June – but is optimistic the agency will consult industry when it comes to setting the compliance timeline. Meanwhile, industry stakeholders are pushing for international harmonization in the agency’s cosmetic GMPs rulemaking.